H-Index
79
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
15%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo

Medical Science Monitor Basic Research
AmJCaseRep

Annals
ISI-Home

eISSN: 1643-3750

Haemopexin and uptake of haem by human erythroleukemia (HEL) cells

Hana Cajthamlov‡a, Zbynek Hrkal, Dana Grebenov‡a, Ursula Muller-Eberhard, Richard J. Stockert

Med Sci Monit 1997; 3(3): BR305-312

ID: 500777

Available online: 1997-05-01

Published: 1997-05-01


Uncomplexed haem suppresses the proliferation of human erythroleukemia (HEL) cells, the effect of which can be partially reversed by apo-haemopexin. The process of suppressed proliferation is paralleled by differentiation of the HEL cells accompanied by haemoglobin synthesis. Equivalent amounts of haem supplied to the cells in the form of haem-haemopexin neither affected their proliferation nor promoted haemoglobin synthesis. Haemopexin internalization by HEL cells only occurred if the haem-haemopexin complexes were continuously supplied to the cells at 37 °C. It suggests that fluid flow endocytosis rather than receptor mediated endocytosis is operative in this process.

Keywords: haem, haemopexin, HEL, proliferation, receptor



Back